Business Context and Reporting Period
This Form 8-K is filed by OncoGenex Pharmaceuticals, Inc. (noted as "ACHIEVE LIFE SCIENCES, INC." in metadata, but identified as OncoGenex in the filing text) on August 6, 2009. The report discloses the issuance of a press release regarding financial results for the quarter ended June 30, 2009.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period. It serves solely as a notification that the quarterly results have been announced via a press release.
Guidance, Outlook, and Risks
The filing does not contain management commentary, guidance, outlook, or specific risk factors. It notes that the attached press release is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference in filings under the Securities Act of 1933.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the press release dated August 6, 2009).
- Confirm the company name discrepancy between the metadata ("ACHIEVE LIFE SCIENCES, INC.") and the filing text ("ONCOGENEX PHARMACEUTICALS, INC.").
- Review the full press release for any forward-looking statements or operational updates not summarized in this 8-K.